Answers are grounded in this paper and cite their sources.
The rapid emergence of multidrug-resistant Escherichia coli emphasizes the need to explore new infection-specific radiopharmaceuticals enabling accurate diagnosis. Natural bioactive compounds remain under-explored for such type of bacterial infection diagnosis. Quercetin, being the major flavonoid exhibits antimicrobial and anti-inflammatory properties, from Moringa oleifera leaves, making it a promising candidate for radiopharmaceutical development. This study aimed to radiolabel quercetin with technetium-99 m through optimized conditions to evaluate its radiochemical purity and in-vitro stability. [ 99m Tc]Tc-quercetin was developed by systematically varying ligand and reducing-agent concentrations, pH, and incubation time using a single-vial formulation. labeling efficiency and radiochemical purity were assessed by Instant thin-layer chromatography and radio-High performance liquid chromatography followed by biodistribution studies in mice and scintigraphic assessment in rabbits to evaluate its infection associated localization potential. The radiolabeling [ 99m Tc]Tc-quercetin presented a highest yield of ≥ 97.82 ± 0.63% achieved through optimized method at 5 mg of quercetin, SnCl₂.H 2 O (25 µg), pH(7) and incubation time of 30 min, confirmed by instant thin-layer chromatography (ITLC). [ 99m Tc]Tc-quercetin presented an excellent in vitro stability for up to 4 h and its biodistribution studies demonstrated rapid blood clearance with predominant renal excretion in mice. The biodistribution and scintigraphic studies showed significantly higher uptake at the site of Escherichia coli infected mice model, confirmed selective localization of [ 99m Tc]Tc-quercetin in rabbits with enhanced accumulation at infected site. [ 99m Tc]Tc-quercetin exhibited high radiochemical yield, stability and proved as potential diagnostic agent for the detection of Escherichia coli bacterium and supports its role as a cost-effective radiopharmaceutical, particularly in regions with limited access to advanced imaging modalities.
No takes yet. Share an insight, caveat, or question.
Tariq et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: